alendronate has been researched along with Osteomyelitis in 15 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our aims were to evaluate if the risk of surgically treated ONJ increases with longer or more compliant treatment with alendronate for osteoporosis and to identify risk factors for surgically treated ONJ." | 7.85 | Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users. ( Abrahamsen, B; Eastell, R; Eiken, PA; Prieto-Alhambra, D, 2017) |
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 7.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "We report a case of diffuse sclerosing osteomyelitis of the mandible responded to alendronate, after a poor response to intravenous antibiotics, antibiotic irrigation-perfusion, and decortication." | 7.73 | Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy. ( Hamakawa, H; Hino, S; Murase, R; Shintani, S; Terakado, N, 2005) |
| "Osteomyelitis is a progressive destruction of bones caused by microorganisms." | 5.42 | Alendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitis. ( Boratto, FA; Cardoso, VN; Fernandes, SO; Ferreira, Ddos S; Ferreira, LA; Oliveira, MC; Serakides, R, 2015) |
| "Tibial osteomyelitis was induced in 72 Wistar albino rats with Staphylococcus aureus ATCC 25923 strain." | 5.35 | Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis. ( Aktekin, CN; Altay, M; Erdemli, E; Karahuseyinoglu, S; Korkusuz, F; Ozturk, AM; Tabak, AY, 2008) |
| " Here, we show that administration of anti-resorptive agents such as the bisphosphonate alendronate accelerates osteonecrosis promoted by infectious osteomyelitis." | 3.85 | Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. ( Ishihara, K; Ishii, K; Iwakura, Y; Iwasaki, R; Kawana, H; Keneko, Y; Kobayashi, T; Matsumoto, M; Miyamoto, K; Miyamoto, T; Morita, M; Nakagawa, T; Nakamura, M; Nakamura, S; Oike, T; Sato, Y; Watanabe, R, 2017) |
| " Our aims were to evaluate if the risk of surgically treated ONJ increases with longer or more compliant treatment with alendronate for osteoporosis and to identify risk factors for surgically treated ONJ." | 3.85 | Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users. ( Abrahamsen, B; Eastell, R; Eiken, PA; Prieto-Alhambra, D, 2017) |
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 3.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "We report a case of diffuse sclerosing osteomyelitis of the mandible responded to alendronate, after a poor response to intravenous antibiotics, antibiotic irrigation-perfusion, and decortication." | 3.73 | Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy. ( Hamakawa, H; Hino, S; Murase, R; Shintani, S; Terakado, N, 2005) |
| "She had been treated for postmenopausal osteoporosis with 70 mg of alendronate weekly for 2 years." | 1.91 | A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture. ( Fernandes, TL; Franco, GCN; Jitumori, C; Viezzer Fernandes, B, 2023) |
| "Tibial osteomyelitis was induced in 72 Wistar albino rats with Staphylococcus aureus ATCC 25923 strain." | 1.35 | Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis. ( Aktekin, CN; Altay, M; Erdemli, E; Karahuseyinoglu, S; Korkusuz, F; Ozturk, AM; Tabak, AY, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes, TL | 1 |
| Viezzer Fernandes, B | 1 |
| Jitumori, C | 1 |
| Franco, GCN | 1 |
| Yang, X | 1 |
| Zhou, K | 1 |
| Shang, W | 1 |
| Song, K | 1 |
| Kamble, S | 1 |
| Valtchev, P | 1 |
| Dao, A | 1 |
| Pelras, T | 1 |
| Rogers, MJ | 1 |
| Savage, PB | 1 |
| Dehghani, F | 1 |
| Schindeler, A | 1 |
| Morita, M | 1 |
| Iwasaki, R | 1 |
| Sato, Y | 1 |
| Kobayashi, T | 1 |
| Watanabe, R | 1 |
| Oike, T | 1 |
| Nakamura, S | 1 |
| Keneko, Y | 1 |
| Miyamoto, K | 1 |
| Ishihara, K | 1 |
| Iwakura, Y | 1 |
| Ishii, K | 1 |
| Matsumoto, M | 1 |
| Nakamura, M | 1 |
| Kawana, H | 1 |
| Nakagawa, T | 1 |
| Miyamoto, T | 1 |
| Hirano, D | 1 |
| Chiba, K | 1 |
| Yamada, S | 1 |
| Ida, H | 1 |
| Eiken, PA | 1 |
| Prieto-Alhambra, D | 1 |
| Eastell, R | 1 |
| Abrahamsen, B | 1 |
| Ferreira, Ddos S | 1 |
| Boratto, FA | 1 |
| Cardoso, VN | 1 |
| Serakides, R | 1 |
| Fernandes, SO | 1 |
| Ferreira, LA | 1 |
| Oliveira, MC | 1 |
| Hoefert, S | 1 |
| Schmitz, I | 1 |
| Tannapfel, A | 1 |
| Eufinger, H | 1 |
| Pazianas, M | 1 |
| Vestergaard, P | 1 |
| Schwartz, K | 1 |
| Rejnmark, L | 1 |
| Mosekilde, L | 1 |
| Pinholt, EM | 1 |
| Bartl, R | 1 |
| Jacobsen, C | 1 |
| Metzler, P | 1 |
| Rössle, M | 1 |
| Obwegeser, J | 1 |
| Zemann, W | 1 |
| Grätz, KW | 1 |
| Chun, CS | 1 |
| Hino, S | 1 |
| Murase, R | 1 |
| Terakado, N | 1 |
| Shintani, S | 1 |
| Hamakawa, H | 1 |
| Ozturk, AM | 1 |
| Tabak, AY | 1 |
| Aktekin, CN | 1 |
| Altay, M | 1 |
| Erdemli, E | 1 |
| Karahuseyinoglu, S | 1 |
| Korkusuz, F | 1 |
2 reviews available for alendronate and Osteomyelitis
| Article | Year |
|---|---|
Osteonecrosis of the jaw and the role of macrophages.
Topics: Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone | 2011 |
Chronic recurrent multifocal osteomyelitis of the spine and mandible: case report and review of the literature.
Topics: Alendronate; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Chron | 2004 |
13 other studies available for alendronate and Osteomyelitis
| Article | Year |
|---|---|
A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Fractures, | 2023 |
Oral administration of alendronate and vitamin D3 for the treatment of chronic non-bacterial osteomyelitis of the jaw.
Topics: Administration, Oral; Alendronate; Child, Preschool; Cholecalciferol; Female; Humans; Mandible; Oste | 2020 |
Synthesis and Characterization of Bone Binding Antibiotic-1 (BBA-1), a Novel Antimicrobial for Orthopedic Applications.
Topics: 3T3 Cells; Alendronate; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bone and Bones; Calci | 2021 |
Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis.
Topics: Alendronate; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation | 2017 |
Oral alendronate in pediatric chronic recurrent multifocal osteomyelitis.
Topics: Administration, Oral; Adolescent; Alendronate; Bone Density Conservation Agents; Female; Humans; Ost | 2017 |
Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Bisphosphonate-Associated Osteonecrosis | 2017 |
Alendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitis.
Topics: Alendronate; Animals; Ceftizoxime; Liposomes; Organotechnetium Compounds; Osteomyelitis; Rats; Rats, | 2015 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Di | 2010 |
Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.
Topics: Administration, Oral; Aged; Alcoholism; Alendronate; Bisphosphonate-Associated Osteonecrosis of the | 2012 |
[Inflammation of the jaws during treatment with bisphosphonates].
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseas | 2011 |
Osteopathology induced by bisphosphonates and dental implants: clinical observations.
Topics: Actinomycosis; Administration, Intravenous; Administration, Oral; Alendronate; Anti-Bacterial Agents | 2013 |
Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy.
Topics: Adult; Alendronate; Facial Pain; Follow-Up Studies; Humans; Infusions, Intravenous; Mandible; Mandib | 2005 |
Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis.
Topics: Alendronate; Animals; Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Transplantation; | 2008 |